These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2020726)

  • 21. Hepatitis D virus infection in a hyperendemic area of chronic hepatitis B virus infection: the Taiwan experience.
    Chen DS; Lai MY; Chen PJ; Sheu JC; Yang PM; Sung JL
    Prog Clin Biol Res; 1991; 364():75-80. PubMed ID: 2020724
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevalence of anti-delta antibodies in pregnant women in Bandung, Indonesia.
    Vranckx R; Reniers J; Alisjahbana A; Ngantung W; Sugita E; Meheus A
    Trop Geogr Med; 1988 Jan; 40(1):17-9. PubMed ID: 3381311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Incidence of hepatitis D virus infection in chronic hepatitis B virus carriers].
    Hacibektaşoğlu A; Barut A; Inal A
    Mikrobiyol Bul; 1992 Jul; 26(3):224-32. PubMed ID: 1528142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of hepatitis B infection in the Western Pacific and South East Asia.
    Gust ID
    Gut; 1996; 38 Suppl 2(Suppl 2):S18-23. PubMed ID: 8786047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of delta virus infection in Venezuelan high-risk population for hepatitis B virus.
    Machado IV; Deibis L; Zabaleta M; Toro FI; Marino V; Ramirez JL; DePerez FE; Bianco NE
    Prog Clin Biol Res; 1991; 364():105-13. PubMed ID: 2020687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surveillance of hepatitis delta virus infection in Colombia, South America.
    Buitrago B; Martinez M; Hadler SC; Maynard JE; Boshell J; Rossi F; Espinal CA; Shapiro C
    Prog Clin Biol Res; 1991; 364():115-22. PubMed ID: 2020688
    [No Abstract]   [Full Text] [Related]  

  • 27. Current seroepidemiology of hepatitis D virus infection among hepatitis B surface antigen carriers of general and high-risk populations in Taiwan.
    Chen CJ; Tseng SF; Lu CF; Lin HC; You SL; Chen CS; Hwang SJ; Hsieh SF; Hsu ST
    J Med Virol; 1992 Oct; 38(2):97-101. PubMed ID: 1460460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis delta virus infection: a recently imported disease in New Zealand.
    Ramirez AM; Lee SP; Woodfield DG
    N Z Med J; 1987 Apr; 100(822):235-7. PubMed ID: 3454892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Certification of poliomyelitis eradication. WHO Western Pacific Region, October 2000.
    Wkly Epidemiol Rec; 2000 Dec; 75(49):399-400. PubMed ID: 11189701
    [No Abstract]   [Full Text] [Related]  

  • 30. High prevalence of hepatitis delta virus infection detectable by enzyme immunoassay among apparently healthy individuals in Mongolia.
    Inoue J; Takahashi M; Nishizawa T; Narantuya L; Sakuma M; Kagawa Y; Shimosegawa T; Okamoto H
    J Med Virol; 2005 Jul; 76(3):333-40. PubMed ID: 15902700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiological aspects of viral hepatitis B and delta-hepatitis in selected population from Białystok District, Poland.
    Borón P; Borón-Kaczmarska A; Bobrowska E; Kamińska H; Lapiński W
    Infection; 1989; 17(3):175-6. PubMed ID: 2786851
    [No Abstract]   [Full Text] [Related]  

  • 32. Epidemiology of HDV infection in Southern Italy.
    Giusti G; Sagnelli E
    Prog Clin Biol Res; 1987; 234():367-77. PubMed ID: 3628387
    [No Abstract]   [Full Text] [Related]  

  • 33. Epidemiology of hepatitis delta virus and non-A, non-B hepatitis.
    Nordenfelt E
    Scand J Infect Dis Suppl; 1990; 69():49-53. PubMed ID: 1967120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Incidence of the HBsAg carrier state among pregnant women and its effect on the newborn infant. II. The presence of hepatitis B and delta markers in the umbilical cord serum of infants born to mothers who are HBsAg carriers].
    Iliev B; Stambolov B; Khristov M
    Akush Ginekol (Sofiia); 1987; 26(5):22-5. PubMed ID: 3434699
    [No Abstract]   [Full Text] [Related]  

  • 35. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey.
    Celen MK; Ayaz C; Hosoglu S; Geyik MF; Ulug M
    Saudi Med J; 2006 May; 27(5):617-20. PubMed ID: 16680248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Epidemiology and clinical aspects of chronic viral hepatitis].
    Heintges T; Niederau C; Niederau M; Stremmel W
    Z Gastroenterol; 1993 Nov; 31 Suppl 5():42-5. PubMed ID: 8197800
    [No Abstract]   [Full Text] [Related]  

  • 37. Virological and epidemiological features of hepatitis delta infection among blood donors in Nouakchott, Mauritania.
    Mansour W; Bollahi MA; Hamed CT; Brichler S; Le Gal F; Ducancelle A; Lô B; Gordien E; Rosenheim M; Lunel F
    J Clin Virol; 2012 Sep; 55(1):12-6. PubMed ID: 22704272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology and clinical outcome of hepatitis D virus infection in Turkey.
    Balik I; Onul M; Tekeli E; Caredda F
    Eur J Epidemiol; 1991 Jan; 7(1):48-54. PubMed ID: 2026223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An overview of hepatitis D virus infection in Africa and the Middle East.
    Toukan AU
    Prog Clin Biol Res; 1993; 382():251-8. PubMed ID: 8502689
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatitis B virus carrier prevalence in New Zealand: population estimates using the 1987 police and customs personnel survey.
    Blakely T; Salmond C; Tobias M
    N Z Med J; 1998 Apr; 111(1064):142-4. PubMed ID: 9612475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.